stemsavelogo

Select Country

877-783-6728 (877-StemSave)

StemSave Blog

Degenerative Disc Disease Treatment With Autologous Stem Cells

Posted by pamela@stemsave.com on Oct 11, 2016 1:17:53 PM

ddd.pngA published report in Surgical Technology International cites the benefits of using autologous [the patient’s own] mesenchymal stem cells [MSCs] to effectively treat degenerative disc disease (DDD). The study also found that the use of stem cells to augment spinal fusion surgery demonstrated an efficacy that met the gold standard for iliac crest bone graft in posterolateral fusion models.

In a review of the published report, Dr. Kenneth K. Hansraj, Chief of Spine Surgery at New York Spine Surgery & Rehabilitation Medicine, stated that “With back problems being a leading culprit of pain both nationally and internationally, the findings of MSC’s to support degenerative disc disease and degenerative spinal conditions can positively impact the lives of countless people across the globe,” said Dr. Hansraj.  

As regenerative engineering progresses, the study demonstrates that the best stem cells to use in emerging treatments will be the patient’s own [autologous stem cells] as this negates the need to find a suitable donor and eliminates the chances of rejection of the transplanted tissue. To learn more about banking your own valuable stem cells to insure your family’s future health, visit StemSave or call 877-783-6728 (877-StemSave) today.

 

The Future of Regenerative Medicine is Now™

To view the full article, click here.

 

Topics: Degenerative Disc Disease, stem cell treatments, mesenchymal stem cells, autologous stem cells, spinal fusion surgery

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

    Recent Posts

    Posts by Topic

    see all